Free press releases distribution network?

Agency / Source: Sahajanand Medical Technologies (SMT)

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Sahajanand Medical Technologies Sirolimus Eluting Stent Shows Excellent Outcomes -
Sahajanand Medical Technologies Sirolimus Eluting Stent Shows Excellent Outcomes

 

PRZOOM - /newswire/ - Surat, Gujarat, India, 2008/11/13 - "Sirolimus Eluting Stent for leading drug eluting Stents developer & manufacturer Sahajanand Medical Technologies Pvt. Ltd. (SMT) displayed positive results in MAXIMUS trial that included 100 patients from the Max Heart institute in India".

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Sahajanand Medical Technologies Pvt. Ltd. (SMT), Surat, India, leading developer and manufacturer of drug-eluting Stents, welcomed the positive results achieved by Supralimus Core™ (Sirolimus Eluting Stents on unique chromium cobalt platform with a biodegradable Polymer) in the MAXIMUS trial.

MAXIMUS trial was designed to assess the safety and efficacy of the Supralimus-Core™ (Sirolimus Eluting Stent) in de novo native obstructive coronary artery disease. It included 100 patients from the prestigious Max Heart institute in India.

The study population was reflective of “real world” patients with smaller vessels, high incidence of diabetes (36%) and other cardiovascular risk factors.

The 8-months angiographic results, analyzed by Cardialysis (Rotterdam, Netherlands) showed extremely low TLR (Target Lesion Revascularization) at (1%) Stent Thrombosis (2%) at 1 year and low angiographic in-segment restenosis rates (4.6%) at 8 months. The results compare favorably to other drug eluting Stents current in clinically practice.

The 12 month results of MAXIMUS, which were unveiled by Dr. Ashok Seth (Chairman and Chief cardiologist, Escorts Heart Institute, New Delhi, India) on Monday, October 12th at the Transcatheter Cardiovascular Therapeutics (TCT) conference in Washington, DC.

“The results of Supralimus-Core in a real world population with high incidence of diabetes and relatively smaller vessels are extremely promising. It also has the additional advantage of biodegradable polymer which disappears over a period of time then alleviating some of the concern related to persistent polymer hypersensitivity.” Dr Seth commented.

Dr Atul Abhyankar, Medical Director- Sahajanand's Medical Technologies, shared the enthusiasm "The results of TLR and MACE are very low, especially the low Stent thrombosis rates at one year are very impressive and encourage us to further document these results in larger comparative trials.”

Mr. Dhirajlal Kotadia, the Founder and Chairman of SMT; shared the importance of the company's commitment to continuously trying to address unmet medical needs and provide patients and clinicians with choice. We will continue our investment in clinical research and ensure the delivery of evidence-based treatments to all deserving patients around the world.” he added.

Sahajanand Medical Technologies is a global developer and manufacturers of minimally invasive coronary stents, with one of the broadest product portfolios in the industry. (Infinnium, Infinicore, Supralimus, Supracore, Coronnium and Matrix).

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Sahajanand Medical Technologies (SMT)

 
 

Availability: All Metropolitan Area

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Sahajanand Medical Technologies Sirolimus Eluting Stent Shows Excellent Outcomes

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: J P Dutta - SahMed.com 
+91-261-245-1451 pr[.]sahmed.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Sahajanand Medical Technologies (SMT) securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Sahajanand Medical Technologies (SMT) / Company Profile


Read Medical Services/Equipment Most Recent Related Press Releases:

Traditional Mass Spectrometers Give Way to High-resolution Technologies Such as MALDI-TOF Finds Frost & Sullivan
AccuVein, Inc. Named A Best Place to Work in Medical Sales for Second Consecutive Year
Ansell Limited Acquires Cleanroom and Healthcare Consumables Manufacturer Nitritex Limited
ZOLL to Showcase Expanded Portfolio of Advanced Resuscitation and Acute Critical Care Technologies at Arab Health 2017
Frost & Sullivan Awards Ansell for Entrenching itself in the Hand Protection Market with its Visionary Products and Technologies
ZOLL RescueNet ePCR Achieves Latest National Compliance Standard
Eye Tech Care Wins Top Honours from Frost & Sullivan for Developing the EyeOP1, the Only Computer-assisted System for Glaucoma Therapy
Frost & Sullivan Recognizes Nuvectra’s Pioneering Spinal Cord Stimulation Product for Chronic Pain Management
GE Healthcare to Commercialize Rapiscan® Outside the US, Canada & Mexico for Increased Access to Heart Exams
Novel Home Care Needs and Customer Preferences Catalyse Growth Opportunities in Mature Cardiac Monitoring Market Finds Frost & Sullivan

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  NAKIVO, Inc.

Visit  Al Rowaad Advocates & Legal Consultants

Visit  JobsWare.com







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today